glp-1 shortage us = Over FDA is moving to restrict

The addition of that third pathway (glucagon) makes a massive difference in overall effectiveness

Diabetes Spectrum

The therapeutic effects of TGR5 agonists could be improved in combinatorial therapy

The chronic interaction of GIPR and GLP-1R signaling, GLP-1R antagonists, and longer-acting GIPRAs for human benefit will be helpful strategies to light up on the open explorations

As of the end of 2023, Noom had roughly 1.5M paying subscribers paying anywhere from $17/month to $70/month depending on the length of their subscription renewal cycle for access to the paid features in the appthe coaching, community, and content

there are a lot of potential problems that they pose. What are GLP-1 drugs and why are they so costly